Enter the world’s third-largest market for pharma and medical devices. Japan’s pharmaceutical market size (2018) is $85 billion (USD), with 125 million inhabitants. In comparison, the German market is $52 billion (USD).

Japan has some of the highest healthcare standards in the world, with the Japanese government providing health insurance for approximately 99% of its citizens. Japan is an aging society, with 27% of population over 65 years old. This creates a strong demand healthcare innovations and fertile ground for healthcare companies.

Entering a new market provides many opportunities, but also opens the door to unknown risks that need to be assessed as thoroughly as possible. With our network and expertise, we will help you to define your market access strategy, support you to go in directly or to find the right partner, and get your product registered and reimbursed.

Our services

The U.S. medical device manufacturers market was valued at $176.7 billion (USD) in 2020 and is anticipated to exhibit a compound annual growth rate (CAGR) of 5.0% over the forecast period. Key market drivers include the rising prevalence of chronic diseases and the country’s growing geriatric population.

Market access for medical devices in the USA differs considerably from the European model. In Europe, the manufacturer must declare its product’s conformity with an array of legal requirements. In the USA, medical devices are in the competence of the federal agency FDA (Food and Drug Administration).

Our services

Introducing a new product into the European healthcare market requires specialized skills and experience. Once your medical device complies with the EU regulations, it will receive a CE mark. Only then can start to commercialize your products in 32 European countries with a total of 500 million inhabitants.

The European medical technology market was estimated to be worth roughly €140 billion in 2020. The biggest medical device markets in Europe are Germany, France, the United Kingdom, Italy and Spain. Based upon manufacturer prices, the European medical device market is estimated to make up 27.6% of the global market. It is the second largest medical device market after the USA, which represents 41.6% of the global market.

Our services

Weak company performance is most commonly associated with the lack of a clear strategy. Markets are changing fast. New competitors appear every day, and new innovations are appearing at a breakneck pace. The traditional approach — to wait for a change in the environment, and then react to it — doesn’t work anymore.

New strategy models based on agility, predictability and fast realignment are now the new norm. Business Development and Strategy Consulting are therefore becoming more and more critical to success.

Our services

Fundraising is always a challenge, no matter if you are looking for early-stage or growth-stage investment in your life sciences company.

With help from our contacts in leading venture capital and private equity firms focused exclusively on the healthcare industry, we are exceptionally well-positioned to support your growth strategy. Our partners serve as a strategic and financial partners to small and middle-market businesses throughout the European healthcare system, including pharma, medical devices & technology, healthcare IT and consumer health.

Our services

During the last decade, the healthcare sector has changed rapidly.

Due to increased competition and the growing influence of patient associations, delivering healthcare services in a more efficient and effective manner has become increasingly important. As such, supply chain management now plays a critical role in the successful launch your product.

Our services